Gene therapy startup StrideBio signs collaboration deal with Duke University
StrideBio, an emerging startup focusing on gene therapies which closed on a big $81.5 million round of venture capital in March, is partnering with Duke University as it expands efforts to create next-generation therapies.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed